Trichoderma harzianum Rifai strain KRL-AG2 and its associated end-use products : consultation document.: H113-27/2017-20E-PDF

"Trichoderma harzianum Rifai strain KRL-AG2 is a fungus that protects plants from disease-causing fungal pathogens. Trichoderma harzianum Rifai strain KRL-AG2 is a biological fungicide registered for the suppression of root and foliar diseases on greenhouse crops, outdoor nursery plants and agricultural field crops. It can be applied as a soil drench, bulb dip, seed treatment, and as a ground foliar spray. This document presents the proposed regulatory decision for the re-evaluation of Trichoderma harzianum Rifai strain KRL-AG2 including the proposed risk mitigation measures to further protect human health and the environment, as well as the science evaluation on which the proposed decision was based. All products containing Trichoderma harzianum Rifai strain KRL-AG2 registered in Canada are subject to this proposed re-evaluation decision"--p. 1.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847438&sl=0

Publication information
Department/Agency Canada. Health Canada.
Canada. Pest Management Regulatory Agency.
Title Trichoderma harzianum Rifai strain KRL-AG2 and its associated end-use products : consultation document.
Series title Proposed re-evaluation decision, 1925-0967 ; PRVD2017-20
Publication type Series - View Master Record
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Trichoderma harzianum Rifai et ses préparations commerciales apparentées : document de consultation.
Cover title.
“17 November 2017.”
Includes bibliographical references.
Issued also in print format.
Publishing information Ottawa : Pest Management Regulatory Agency, Health Canada, 2017.
Description 19 p.
Catalogue number
  • H113-27/2017-20E-PDF
Subject terms Fungicides
Certification
Toxicology
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: